awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q36719024-655C4ED7-8894-4CD4-B420-A6B40FA7FD30
Q36719024-655C4ED7-8894-4CD4-B420-A6B40FA7FD30
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36719024-655C4ED7-8894-4CD4-B420-A6B40FA7FD30
A phase 3 randomized, double-blind, placebo-controlled trial of ganitumab or placebo in combination with gemcitabine as first-line therapy for metastatic adenocarcinoma of the pancreas: the GAMMA trial.
P2860
Q36719024-655C4ED7-8894-4CD4-B420-A6B40FA7FD30
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36719024-655C4ED7-8894-4CD4-B420-A6B40FA7FD30
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
084298698e2013d11f59f77a9455571da5725ed6
P2860
A randomized, placebo-controlled phase 2 study of ganitumab (AMG 479) or conatumumab (AMG 655) in combination with gemcitabine in patients with metastatic pancreatic cancer.